Try our Advanced Search for more refined results
Searching dockets in Abbvie Inc x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Qui Tam (31 U.S.C. § 3729(a)) | California Central
Order ~Util - Set/Reset Deadlines/Hearings
ORDER GRANTING JOINT STIPULATION REGARDING SCHEDULING ORDER 192 by Judge Dale S. Fischer. The Court, having considered the Parties' Joint Stipulation Regarding the Scheduling Order, GRANTS the Stipulation and ORDERS that the Schedule of Pretrial and Trial Dates shall be established in accordance with Exhibit A to the Parties' Joint Stipulation Regarding the Scheduling Order, as entered by the Court. Motions to Dismiss shall be filed by 7/3/2028., Jury Trial set for 10/10/2028 08:30 AM before Judge Dale S. Fischer., Pretrial Conference set for 9/11/2028 03:00 PM before Judge Dale S. Fischer. (SEE DOCUMENT FOR FURTHER DETAILS.) (rolm)
P.I.: Other | Ohio Northern
Reply
Reply in support of 6648 Motion by Third Party Payor Plaintiffs' for (1) Final Approval of Class Action Settlement with Allergan, Janssen, Teva, and Settling Pharmacies; and (2) Award of Attorneys' Fees and Expenses and Settlement Class Representative Servic filed by Plaintiff Counsel. (Dearman, Mark)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
Phone
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 UK may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.